Ani Pharmaceuticals (ANIP) Net Shares Issued and Repurchased (2014)
Ani Pharmaceuticals (ANIP) reported Net Shares Issued and Repurchased of -$20000.0 for Q2 2014, down 100.04% sequentially from $46.7 million in Q1 2014.
Ani Pharmaceuticals (ANIP) Net Shares Issued and Repurchased (2014) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 1 years of Net Shares Issued and Repurchased data on file, last reported at -$20000.0 in Q2 2014.
- For the quarter ending Q2 2014, Net Shares Issued and Repurchased changed N/A year-over-year to -$20000.0; the trailing twelve-month figure through Mar 2015 stood at -$20000.0 (down 100.04% YoY), and the FY2014 full-year result was $46.7 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased retreated to -$20000.0 in Q2 2014, from $46.7 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $46.7 million in Q1 2014 to a low of -$20000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | -20,000.00 |
| Jun 30, 2014 | -20,000.00 |
| Mar 31, 2014 | 46.69 Mn |
| Mar 31, 2014 | 46.69 Mn |